The company remains entirely pre-revenue, with operating losses widening to $7.6 million in 2026Q3 as R&D expenditures surged to $5.8 million.
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - |
| Cost of Goods Sold | 57.08K | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - |
| Gross Profit | -135.51K | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - |
| Operating Expenses | 22.62M | 13.59M | 4.62M | 1.46M | 1.78M |
| OpEx % of Revenue | - | - | - | - | - |
| Selling, General & Admin | 11.77M | 9.93M | 3.74M | 787K | 1.09M |
| SG&A % of Revenue | - | - | - | - | - |
| Research & Development | 13.64M | 3.66M | 880K | 676K | 666.02K |
| R&D % of Revenue | - | - | - | - | - |
| Other Operating Expenses | -1.02M | 0 | 0 | 0 | 23.98K |
| Operating Income | -22.68M | -13.59M | -4.62M | -1.46M | -1.78M |
| Operating Margin % | - | - | - | - | - |
| Operating Income Growth % | - | -193.79% | -216.06% | 17.81% | - |
| EBITDA | -22.45M | -13.45M | -4.57M | -1.44M | -1.76M |
| EBITDA Margin % | - | - | - | - | - |
| EBITDA Growth % | -93.85% | -194.37% | -218.11% | 18.21% | - |
| D&A (Non-Cash Add-back) | 227.08K | 138K | 56K | 27K | 24.26K |
| EBIT | -33.76M | 5.2M | -8M | -1.25M | -1.65M |
| Net Interest Income | 684.42K | 120.96K | -164.32K | -74.33K | -2.15K |
| Interest Income | 684.42K | 120.96K | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 164.32K | 0 | 0 |
| Other Income/Expense | -10.4M | 18.79M | -3.54M | 216K | 127.82K |
| Pretax Income | -33.07M | 5.2M | -8.16M | -1.25M | -1.65M |
| Pretax Margin % | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% |
| Net Income | -33.03M | 5.2M | -8.16M | -1.25M | -1.65M |
| Net Margin % | - | - | - | - | - |
| Net Income Growth % | -426.57% | 163.73% | -554.37% | 24.52% | - |
| Net Income (Continuing) | -33.03M | 5.2M | -8.16M | -1.25M | -1.65M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.75 | 0.17 | -0.76 | -0.17 | -0.24 |
| EPS Growth % | -321.08% | 122.37% | -347.06% | 29.17% | - |
| EPS (Basic) | - | 0.20 | -0.76 | -0.17 | -0.24 |
| Diluted Shares Outstanding | 44.33M | 30.76M | 10.72M | 7.33M | 6.9M |
| Basic Shares Outstanding | 44.33M | 25.84M | 10.72M | 7.33M | 6.9M |
| Dividend Payout Ratio | - | - | - | - | - |
Binary certification failure risk
As indicated by the company's financial disclosures, HOVR remains entirely pre-revenue, with no commercial sales recorded across the last ten quarters, underscoring the speculative nature of its current development-stage business model as it works toward achieving necessary aerospace certification for the Cavorite X7 platform.
The absence of revenue confirms that the company is currently in a pure-play R&D phase where commercial traction is measured by non-binding letters of intent rather than GAAP figures. Investors should monitor whether the company can transition from this theoretical revenue model to actual production, as the current lack of sales leaves the firm entirely dependent on external capital to fund operations.
According to the provided income statement data, HOVR's quarterly research and development spending has surged from $219,000 in 2024Q2 to $5.8 million by 2026Q3, reflecting a significant acceleration in prototype development and engineering activities required to meet stringent regulatory safety standards.
This rapid increase in R&D spending suggests that the company is entering a more capital-intensive phase of its certification timeline. The rising cost structure implies that management is prioritizing technical milestones, though this trajectory necessitates a careful evaluation of the company's remaining cash runway to ensure it can sustain these levels of investment.
Based on reported figures, HOVR recorded $5.8 million in stock-based compensation during 2026Q3, a figure that matches its total R&D spend for the same period and highlights the significant reliance on equity-based incentives to attract and retain specialized engineering talent in a competitive aerospace labor market.
The high ratio of stock-based compensation to total operating expenses suggests that the company is managing its cash burn by utilizing equity, which may lead to future dilution for existing shareholders. Analysts should scrutinize the impact of these non-cash charges on the overall net loss, as they mask the true underlying cash requirements of the business.
As reported in financial statements, the company's operating loss has widened significantly from $824,000 in 2024Q2 to $7.6 million in 2026Q3, demonstrating that operating expenses are scaling rapidly without any corresponding revenue growth to offset the mounting fixed costs of the business.
The lack of operating leverage is typical for a pre-revenue aerospace firm, but the widening gap between R&D/SG&A and revenue suggests that the company is becoming increasingly expensive to operate. This trend warrants further investigation into whether the current spending levels are yielding proportional progress in flight testing and regulatory certification milestones.
Quick answers to the most common questions about buying HOVR stock.
For fiscal year 2025, New Horizon Aircraft Ltd. (HOVR) reported total revenue of $0.0M.
New Horizon Aircraft Ltd. (HOVR) is profitable, generating $5.2M in net income for the fiscal year ending 2025.